Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ludovic Lacroix

Showing results (141-150 of 180) with videos related to

Pageof 18
Sort By:
Nature Communications|May 3, 2020
Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancerClélia Coutzac, Jean-Mehdi Jouniaux, Angelo Paci, et al.
NPJ Precision Oncology|February 26, 2024
Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patientsDamien Vasseur, Ahmadreza Arbab, Fabiola Giudici, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2018
Human epidermal receptor family inhibitors in patients with ERBB3 mutated cancers: Entering the back doorLoic Verlingue, Antoine Hollebecque, Ludovic Lacroix, et al.
The Journal of Molecular Diagnostics : JMD|March 25, 2020
Evaluation of a Hybrid Capture-Based Pan-Cancer Panel for Analysis of Treatment Stratifying Oncogenic Aberrations and ProcessesLeonie I Kroeze, Richarda M de Voer, Eveline J Kamping, et al.
BMC Medical Genomics|December 5, 2013
Integrated molecular portrait of non-small cell lung cancersVladimir Lazar, Chen Suo, Cedric Orear, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2016
Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO TrialCécile Jovelet, Ecaterina Ileana, Marie-Cécile Le Deley, et al.
Cells|June 24, 2022
Next-Generation Sequencing on Circulating Tumor DNA in Advanced Solid Cancer: Swiss Army Knife for the Molecular Tumor Board? A Review of the Literature Focused on FDA Approved TestDamien Vasseur, Hela Sassi, Arnaud Bayle, et al.
Diagnostic and Interventional Imaging|June 8, 2025
Baseline CT-derived tumor burden and liquid biopsy as biomarkers to predict survival in patients with metastatic solid cancerGhina Jardali, Littisha Lawrance, Lama Dawi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 18, 2020
High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni SyndromeLaura Mezquita, Maria Jové, Ernest Nadal, et al.
JCO Precision Oncology|September 14, 2020
Clinical Relevance of an Amplicon-Based Liquid Biopsy for Detecting <i>ALK</i> and <i>ROS1</i> Fusion and Resistance Mutations in Patients With Non-Small-Cell Lung CancerLaura Mezquita, Aurélie Swalduz, Cécile Jovelet, et al.
Pageof 18

Showing results (141-150 of 180) with videos related to

Sort By:
Pageof 18
Nature Communications|May 3, 2020
Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancerClélia Coutzac, Jean-Mehdi Jouniaux, Angelo Paci, et al.
NPJ Precision Oncology|February 26, 2024
Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patientsDamien Vasseur, Ahmadreza Arbab, Fabiola Giudici, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2018
Human epidermal receptor family inhibitors in patients with ERBB3 mutated cancers: Entering the back doorLoic Verlingue, Antoine Hollebecque, Ludovic Lacroix, et al.
The Journal of Molecular Diagnostics : JMD|March 25, 2020
Evaluation of a Hybrid Capture-Based Pan-Cancer Panel for Analysis of Treatment Stratifying Oncogenic Aberrations and ProcessesLeonie I Kroeze, Richarda M de Voer, Eveline J Kamping, et al.
BMC Medical Genomics|December 5, 2013
Integrated molecular portrait of non-small cell lung cancersVladimir Lazar, Chen Suo, Cedric Orear, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2016
Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO TrialCécile Jovelet, Ecaterina Ileana, Marie-Cécile Le Deley, et al.
Cells|June 24, 2022
Next-Generation Sequencing on Circulating Tumor DNA in Advanced Solid Cancer: Swiss Army Knife for the Molecular Tumor Board? A Review of the Literature Focused on FDA Approved TestDamien Vasseur, Hela Sassi, Arnaud Bayle, et al.
Diagnostic and Interventional Imaging|June 8, 2025
Baseline CT-derived tumor burden and liquid biopsy as biomarkers to predict survival in patients with metastatic solid cancerGhina Jardali, Littisha Lawrance, Lama Dawi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 18, 2020
High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni SyndromeLaura Mezquita, Maria Jové, Ernest Nadal, et al.
JCO Precision Oncology|September 14, 2020
Clinical Relevance of an Amplicon-Based Liquid Biopsy for Detecting <i>ALK</i> and <i>ROS1</i> Fusion and Resistance Mutations in Patients With Non-Small-Cell Lung CancerLaura Mezquita, Aurélie Swalduz, Cécile Jovelet, et al.
Pageof 18